Glycopyrrolate Injection
Product Images NDC 51662-1601

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of glycopyrrolate displaying its molecular formula C19H28BrNO3 and molecular weight 398.33. The diagram shows the arrangement of atoms including a bromide ion associated with the quaternary ammonium group.*

FDA Label Image

Clinical (Clinical)

A pharmacokinetic data table showing parameters for Glycopyrrolate administered intravenously (6 µg/kg IV) and intramuscularly (8 µg/kg IM). It includes values for half-life (t1/2), volume of distribution at steady state (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC), with associated error margins and notes.*

FDA Label Image

Vial Label (Vial Label)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL in 5 mL multiple dose vial. The label states it is for intramuscular or intravenous use and contains benzyl alcohol as preservative. Storage instructions specify 20° to 25°C. Distributed by Hikma under labeler HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Serialized Labeling (51662 1601 1 Serialized Vial Labeling)

GLYCOPYRROLATE injection 0.2 mg/mL vial with orange cap, labeled for intravenous and intramuscular use. The vial includes manufacturer information for HF Acquisition Co LLC, DBA HealthFirst. Packaging includes a white label with text and a barcode.*

FDA Label Image

Pouch Labeling (51662 1601 2 Pouch Labeling)

Label for Glycopyrrolate Injection USP 1 mg/5 mL (0.2 mg/mL) in a 5 mL vial. Includes NDC 51662-1601-2, lot number 123456, and expiration date 2030-01-01. The label states it is for intramuscular or intravenous use and contains preservative benzyl alcohol. Manufactured by HF Acquisition Co., LLC in Mukilteo, WA.*

FDA Label Image

Vial Label (51662 1601 2 Vial Label)

Label for Glycopyrrolate Injection, USP 1 mg per 5 mL (0.2 mg/mL) in a 5 mL multiple dose vial. The label includes dosing route as intramuscular and intravenous use and contains benzyl alcohol as a preservative. It states storage conditions at 20° to 25°C and cautions against use in newborns. Distributed by Hikma.*

FDA Label Image

Case Labeling (51662 1601 3 Case Labeling)

Label for Glycopyrrolate Injection USP 1 mg/5 mL (0.2 mg/mL) vial, case of 25, manufactured by HF Acquisition Co LLC. The label includes the NDC 51662-1601-3, lot number 123456, and expiration date 2030-01-01. Indications include intramuscular or intravenous use; contains benzyl alcohol and specifies storage at 20 to 25°C (68 to 77°F).*

FDA Label Image

Rfid Label (51662 1601 3 Case Rfid)

Partial label on a clear plastic pouch showing a white sticker with multiple lines of text including unique identifiers and the distributor information. The label text states distribution by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label includes a QR code and a note to see the manufacturer's insert. The pouch appears sealed with a black strip at the top.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.